Access cutting-edge advanced cancer treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access advanced cancer specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced cancer treatment provided free
This pan-tumor trial is designed as a signal-seeking trial to assess efficacy and safety of raludotatug deruxtecan (R-DXd) monotherapy in locally advanced or metastatic solid tumors with various cadherin-6 (CDH6) expression levels, including gynecological cancers (endometrial cancer, cervical cancer, and non-high-grade serous ovarian cancer) and genitourinary cancers (urothelial cancer and clear cell renal cell carcinoma \[ccRCC\]).
Sponsor: Daiichi Sankyo
Check if you qualify for this advanced cancer clinical trial in Ann Arbor, MI
If you're searching for advanced cancer treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.